Premarket big-cap movers: HUM, CLOV, DNA, CCI, FSLY, AMT, LITE

CMS Star ratings upgrades lifted HUM, CLOV, CCI, FSLY, and AMT; DNA gained on plans to provide autonomous lab access for NSF X-Labs; CCI, FSLY, and AMT also cited positive action after Starling Spectrum wins; LITE rose on CEO comments; BULL and TEVA gained on analyst upgrades and an FDA approval for WELTRUZA.